هم‌سنجی درمان فراشناختی و درمان مبتنی بر فعال‌سازی رفتاری بر ابعاد نشخوار فکری در زنان مبتلا به اختلال افسردگی اساسی
محورهای موضوعی : روانشناسی
مجید جامه بزرگی
1
,
علی آل یاسین
2
,
حسن حیدری
3
,
حسین داودی
4
1 - دانشجوی دکتری روانشناسی عمومی، گروه روانشناسی، دانشکده علوم انسانی، واحد خمین، دانشگاه آزاد اسلامی، خمین، ایران
2 - استادیار، گروه روانشناسی بالینی، دانشکده علوم انسانی، واحد آشتیان، دانشگاه آزاد اسلامی، آشتیان، ایران (نویسنده مسئول) aleyasin_psychology@yahoo.com, tell: 09189872586
3 - دانشیار، گروه مشاوره و روانشناسی، دانشکده علوم انسانی، واحد خمین، دانشگاه آزاد اسلامی، خمین، ایران. heidarihassan@yahoo.com
4 - استادیار، گروه مشاوره و روانشناسی، دانشکده علوم انسانی، واحد خمین، دانشگاه آزاد اسلامی، خمین، ایران
کلید واژه: اختلال افسردگی اساسی, درمان فراشناختی, درمان فعال‌سازی رفتاری, نشخوار فکری,
چکیده مقاله :
چکیده مقدمه: پژوهش‌های متعدد به بالا بودن نشخوار فکری در زنان مبتلا به اختلال افسردگی اساسی اشاره دارند. هدف پژوهش حاضر هم‌سنجی درمان فراشناختی و درمان مبتنی بر فعال‌سازی رفتاری بر ابعاد نشخوار فکری در زنان مبتلا به اختلال افسردگی اساسی بود. روش پژوهش: پژوهش حاضر مطالعه شبه‌آزمایشی با طرح پیش‌آزمون - پس‌آزمون - پیگیری با گروه گواه بود. جامعه آماری این پژوهش شامل کلیه زنان دارای اختلال افسردگی اساسی مراجعه‌کننده به کلینیک‌های روانشناسی مستقر در منطقه 8 شهر تهران بود که تعداد 45 نفر به شیوه هدفمند انتخاب و با گمارش تصادفی در دو گروه آزمایش و یک گروه گواه قرار گرفتند. ابزار این پژوهش پرسشنامه نشخوار فکری بود. برای گروه آزمایش اول درمان فراشناخت و برای گروه آزمایش دوم درمان فعال‌سازی رفتاری در 8 جلسه 90 دقیقه‌ای برگزار شد، اما گروه گواه مداخله‌ای دریافت نکرد. داده‌ها با بهره‌گیری از تحليل واریانس آميخته تجزیه‌وتحلیل شدند. یافته¬ها: نتایج حاکی از آن بود که درمان فراشناختی و درمان فعال‌سازی رفتاری باعث کاهش نشخوار فکری و مؤلفه‌های آن در پایان مداخلات و دوره پیگیری شده بودند (05/0p>). نتایج نشان داد درمان فعال‌سازی رفتاری در کاهش علائم نشخوار فکری، نسبت به درمان فراشناختی اثربخشی بیشتری را نشان می‌دهد (05/0p>). نتیجه‌گیری: درمان فعال‌سازی رفتاری به دلیل تأثیری که بر افسردگی دارد می‌تواند به تنهایی و یا با درمان مکمل در کاهش نشخوار فکری و علائم افسردگی در زنان مبتلا به اختلال افسردگی اساسی مؤثر باشد.
Abstract Introduction: Numerous studies point to the high level of rumination in women with major depressive disorder. The aim of the present study was to compare metacognitive therapy and treatment based on behavioral activation on rumination dimensions in women with major depressive disorder. Methods: The current research was a quasi-experimental study with a pre-test-post-test-follow-up design with a control group. The statistical population of this research included all women with major depressive disorder referring to psychological clinics located in the 8th district of Tehran, 45 of whom were selected in a targeted manner and randomly assigned to two experimental groups and one control group. The instrument of this research was rumination questionnaire. For the first experimental group, metacognitive therapy and for the second experimental group, behavioral activation therapy was held in 8 sessions of 90 minutes, but the control group did not receive any intervention. The data were analyzed using mixed analysis of variance. Results: The results indicated that metacognitive therapy and behavioral activation therapy reduced rumination and its components at the end of the interventions and the follow-up period (p>0.05). The results showed that behavioral activation therapy is more effective in reducing rumination symptoms than metacognitive therapy (p>0.05). Conclusion: Because of its effect on depression, behavioral activation therapy alone or with complementary therapy can be effective in reducing rumination and depression symptoms in women with major depressive disorder.
References:
1. Young JE, Rygh JL, Weinberger AD, Beck AT. Cognitive therapy for depression. In D. H. Barlow (Ed.). Clinical handbook of psychological disorders (250-306). New York: Guilford Press; 2018.
2. Seshadri A, Orth SS, Adaji A, Singh B, Clark MM, Frye MA, McGillivray J, Fuller-Tyszkiewicz M. Mindfulness-Based Cognitive Therapy, Acceptance and Commitment Therapy, and Positive Psychotherapy for Major Depression. American Journal of Psychotherapy. 2021; 74(1): 4-12. https://doi.org/10.1176/appi.psychotherapy.20200006.
3. Omidmehr A, Hekmat H, Kordestani D, Gholami M. The Effectiveness of Mindfulness, Logotherpy and Behavioral Activation Treatment on Negative Automatic Thoughts and Depressed Female Students' Attention. Family and health quarterly. 2020; 10(3): 19-35. (In Persian) http://journal.astara.ir/article_245948.html
4. Levinson DF. The genetics of depression: A review. Biological Psychiatry. 2016; 60: 84-92. https://doi.org/10.1016/j.biopsych.2005.08.024
5. Collins E, Segal Z. Therapeutic mindfulness and depression. In M. H. Trivedi (Ed.), Depression (pp. 357–371). Oxford University Press, 2020.
6. Moore MT, Lau MA, Haigh EAP, Willett BR, Bosma CM, Fresco DM. Association between decentering and reductions in relapse/recurrence in mindfulness-based cognitive therapy for depression in adults: A randomized controlled trial. Journal of Consulting and Clinical Psychology. 2020; 90(2): 137-147. https://doi.org/10.1037/ccp0000718
7. Guo HR, Wang JR, Wang YL, Huang BL, Yang XH, Ren YM. The effectiveness of mindfulness-based cognitive therapy combined with medication therapy in preventing recurrence of major depressive disorder in convalescent patients. Front Psychology. 2020; 18(13): 882006. https://doi.org/10.3389/fpsyg.2022.882006.
8. Sharma V, Sagar R, Kaloiya G, Mehta M. Effectiveness of Metacognitive Therapy in Patients with Depression and Comorbid Anxiety Symptoms: A Case Series From India. Cureus. 2022; 14(4): e24229. https://doi.org/10.7759/cureus.24229
9. Stalmeier TDM, Lubbers J, Cladder-Micus MB, Hanssen I, Huijbers MJ, Speckens AEM, Geurts, DEM. Mindfulness based cognitive therapy (MBCT) reduces depression-related self-referential processing in patients with bipolar disorder: an exploratory task-based study. Cognition and Emotion. 2020; 2: 1-18. doi.org/10.1080/02699931.2022.2105308
10. Abbasi R, Khademloo M. The Effectiveness of Mindfulness-based Cognitive therapy on Schema fectiveness/ shame, rumination and social isolation of women perfectionis. Psychological Studies. 2018; 14(1): 127-145. (In Persian) https://psychstudies.alzahra.ac.ir/article_3136.html
11. Kraines MA, Peterson SK, Tremont GN, Beard C, Brewer JA, Uebelacker LA. Mindfulness-Based Stress Reduction and Mindfulness-Based Cognitive Therapy for Depression: a Systematic Review of Cognitive Outcomes. Mindfulness. 2022; 13: 1126-1135. https://doi.org/10.1007/s12671-022-01841-7
12. Johannsen M, Nissen ER, Lundorff M, O'Toole MS. Mediators of acceptance mindfulness-based therapies for anxiety and depression: A systematic review and meta-analysis. Clinical Psychology Review. 2022: 94: 102156. https://doi.org/10.1016/j.cpr.2022.102156
13. Dimidjian S, Barrera MJr, Martell C, Muñoz RF, Lewinsohn PM. The origins and current status of behavioral activation treatments for depression. Annual Review of Clinical Psychology. 2021; 7(4): 1-38. https://doi.org/10.1146/annurev.clinpsy-032210-104535
14. Mazzucchelli T, Kane R, Rees C. Behavioral activation treatments for depression in adults: a meta‐analysis and review. Clinical Psychology: Science and Practice. 2009; 16(4): 383-411. https://doi.org/10.1111/j.1468-2850.2009.01178.x
15. Leahy RL, Holland SJ, McGinn LK. Treatment plans and interventions for depression and anxiety disorders. 24 Ed, New York: Guilford Press, 2018.
16. Martell CR, Dimidjian S, Herman-Dunn R. Behavioral activation for depression: A clinician's guide. New York: Guilford, 2010.
17. Addis ME, Martell CR. Overcoming depression one step at a time: The new behavioral activation approach to getting your life back. New Harbinger Publications, Incorporated, 2014.
18. Tanrıverdi D, Özgüç S. Metacognitive features and cognitive distortions of the patients with major depression. Current Psychology; 2022. https://doi.org/10.1007/s12144-022-03026-w
19. Daughters SB, Braun AR, Sargeant MN, Reynolds EK, Hopko DR, Blanco C, Lejuez CW. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). Journal of Clinical Psychiatry. 2018; 69(1): 122-129. https://doi.org/10.4088/jcp.v69n0116
20. Rahbaran R, Karami R, Shahmohammadi M. The Effectiveness of Behavioral Activation Therapy on Rhubarb and Depression Disorders in Adolescents. The Journal of Thought & Behavior in Clinical Psychology (JTBCP). 2019; 14(52): 17-26. (In Persian) https://jtbcp.riau.ac.ir/m/article_1539.html
21. Uphoff E, Pires M, Barbui C, Barua D, Churchill R, Cristofalo D, Ekers D, Fottrell E, Mazumdar P, Purgato M, Rana R, Wright J, Siddiqi N. Behavioural activation therapy for depression in adults with non-communicable diseases. Cochrane Database of Systematic Reviews. 2020; 8(8): CD013461. https://doi.org/10.1002/14651858.CD013461.pub2.
22. Stein AT, Carl E, Cuijpers P, Karyotaki E, Smits JAJ. Looking beyond depression: a meta-analysis of the effect of behavioral activation on depression, anxiety, and activation. Psychol Med. 2021; 51(9): 1491-1504. https://doi.org/10.1017/S0033291720000239
23. Moshier SJ, Otto MW. Behavioral activation treatment for major depression: A randomized trial of the efficacy of augmentation with cognitive control training. J Affect Disord. 2017; 210: 265-268. https://doi.org/10.1016/j.jad.2017.01.003
24. Polenick CA, Flora SR. Behavioral activation for depression in older adults: theoretical and practical considerations. Behavior Analyst. 2018; 36(1): 35-55. https://doi.org/10.1007/bf03392291
25. Kharaei K, Azizi M. Effectiveness of behavioral activation on depression, anxiety and increase quality of life for female heads of households in ghaleh- ganj city. JNIP. 2021; 10(14):1-8. (In Persian) http://jnip.ir/article-1-580-fa.html
26. Ataie Moghanloo V, Ataie Moghanloo R. The effect of behavioral activation therapy based on lifestyle changes on depression, psychological well-being and guilt in children aged 7 to 15 years with diabetes. Journal of Rafsanjan University of Medical Sciences. 2015; 14(4): 338-325. http://journal.rums.ac.ir/article-1-2382-fa.html (In Persian)
27. Hauschildt M, Arlt S, Moritz S, Yassari AH, Jelinek L. Efficacy of metacognitive training for depression as add-on intervention for patients with depression in acute intensive psychiatric inpatient care: A randomized controlled trial. Clinical Psychology & Psychotherapy. 2022; 1-14. https://doi.org/10.1002/cpp.2733.
28. Wells A. Metacognitive therapy for anxiety and depression. New York: Guilford Press, 2019.
29. Carter JD, Jordan J, McIntosh VVW, Frampton CMA, Lacey C, Porter RJ, Mulder RT. Long-term efficacy of metacognitive therapy and cognitive behaviour therapy for depression. Australian & New Zealand Journal of Psychiatry. 2022; 56(2): 137-143. https://doi.org/10.1177/00048674211025686
30. Dietrichkeit M, Hagemann-Goebel M, Nestoriuc Y, Mortiz S, Jelinek L. Side effects of the metacognitive training for depression compared to a cognitive remediation training in patients with depression. Scientific Reports. 2021; 12(11): 7861. https://doi.org/10.1038/s41598-021-87198-8.
31. Wells A, Reeves D, Heal C, Davies LM, Shields GE, Heagerty A, Fisher P, Doherty P, Capobianco L. Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme. Front Psychiatry. 2022; 13: 886407. Doi.org/10. 3389/fpsyt.2022.886407
32. Wells A, Fisher P, Myers S, Wheatley J, Patel T, Brewin, C. Metacognitive therapy in treatment-resistant depression: A platform trial. Behavior research and therapy. 2012; 50: 367-373. https://doi.org/10.1016.j.brat.2012.02.004
33. Özgüç S, Tanriverdi D. Effect of metacognitive training applied on depression and cognitive distortion levels of depression patients. Current Psychology. 2021. https://doi.org/10.1007/s12144-021-02202-8
34. Bassaknejad S, Zargar Y, Hatami Sarbarzeh M. The effectiveness of cognitive behavioral group therapy on thought-action fusion, thought suppression and guilty feeling of university students. Cognitive and Behavioral Sciences Research. 2012; 3(1): 23-32. (In Persian) https://cbs.ui.ac.ir/article_17302.html
35. Ansari B, Tasbihsazan S, Khademi A, Rezaei M. Effectiveness of Metacognitive Therapy on Worry, Rumination and Asthma Control in Patients with Asthma. IJRN. 2021; 7(3): 20-29. (In Persian) http://ijrn.ir/article-1-627-fa.html
36. Taheri Daghian A, Ghasemi Motlagh M, Mehdian H. Comparison of the effectiveness of dialectical behavior therapy and metacognitive therapy on reducing depression and rumination in depressed patients. MUMS. 2021; 63(6): 264-275. (In Persian) https://mjms.mums.ac.ir/article_18374.html
37. Winter L, Schweiger U, Kahl KG. Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study. BMC Psychiatry. 2020; 20(1): 566. https://doi.org/10.1186/s12888-020-02976-4
38. Hjemdal O, Solem S, Hagen R, Kennair LEO, Nordahl HM, Wells A. A Randomized Controlled Trial of Metacognitive Therapy for Depression: Analysis of 1-Year Follow-Up. Front Psychol. 2019; 8: 10-1842. https://doi.org/10.3389/fpsyg.2019.01842
39. Bayegan K, Sotodeh Asl N, Karami A, Asadzadeh Dahraei H. Comparison of the Effectiveness of Metacognitive Therapy and Behavioral Activation on Depression in Elderly with Type 2 Diabetes. Avicenna Journal of Neuro Psycho Physiology. 2020; 7(1): 9-14. http://ajnpp.umsha.ac.ir/article-1-305-en.html
40. Schaich A, Heikaus L, Assmann N, Köhne S, Jauch-Chara K, Hüppe M, Wells A, Schweiger U, Klein JP, Fassbinder E. PRO*MDD Study Protocol: Effectiveness of Outpatient Treatment Programs for Major Depressive Disorder: Metacognitive Therapy vs. Behavioral Activation a Single-Center Randomized Clinical Trial. Front Psychiatry. 2018; 9: 584. https://doi.org/10.3389/fpsyt.2018.00584
41. Dimidjian S, Martell CR, Addis ME, Herman-Dunn R. Behavioral activation for depression. In D. H. Barlow (Ed.), Clinical Handbook of Psychological Disorders (328–364). New York: The Guilford Press; 2008.
42. Wells A. Metacognitive therapy: A practical guide, (Ch.9: Major depressive disorder). New York: Guilford press, 2009.
43. Nolen-Hoeksema S, Morrow J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: The 1989 Loma Prieta earthquake. Journal of Personality and Social Psychology. 1991; 61: 115-121. doi.10.1037/0022-3514.61.1.115
44. Bagherinezhad M, Salehi Fadardi J, Tabatabayi SM. The relationship between rumination and depression in a sample of Iranian student. Research in Clinical Psychology and Counseling. 2010; 11(1): 21-38. (In Persian) https://tpccp.um.ac.ir/article_28015.html?lang=fa
45. Tanhaye Reshvanloo F, Torkamani M, Mirshahi S, Hajibakloo N, Kareshki H. Validity and Reliability Assessment of the Persian Version of the Co-Rumination Questionnaire. Journal of clinical psychology. 2021; 13(1): 79-87. (In Persian) https://jcp.semnan.ac.ir/article_5107.html
46. Mortezaei Z, Ali Mirzaei M, Shamsi S. Comparison of metacognitive therapy and stress reduction program therapy based on mindfulness on depression, self-evaluation and emotion regulation in women with postpartum depression. New ideas of psychology. 2017; 1(3): 30-40. http://jnip.ir/article-1-104-fa.htmal (In Persian)
47. Khoshlahjeh A. The effect of metacognitive therapy in reducing symptoms of depression and anxiety in female patients with constipation. Educational Sciences and Psychology. 2017; 6(21): 116-128. https://hpj.journals.pnu.ac.ir/article/-3703.html (In Persian)
48. Ghadampour E, Azizi A, Mohammadi J. Efficacy of detached mindfulness in metacognitive therapy on postpartum depression. Nursing Education. 2017; 5(5): 17-22. http://jne.ir/article-1-738-fa.html (In Persian)
49. Hasanvandi S, Valizadeh M, Mehrabizadeh Honarmand M. The effectiveness of group-based metacognitive therapy on symptoms of depression and rumination. Principles of Mental Health. 2013; 15(57): 142-168. doi.org/10.22038/jfmh.2013.775 (In Persian)
50. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology. 2004; 72(1): 31-40. https://doi.org/10.1037/0022-006x.72.1.31
51. Wells A, Welford M, Fraser J, King P, Mendel E, Wisely J. Chronic treated with metacognitive therapy: An open trial. Cognitive and Behavioral Practice. 2008; 15(2): 85-92. https://doi.org/10.1016/j.cbpra.2006.11.005
52. Wells A, Sembi S. Metacognitive therapy for PTSD: A preliminary investigation of a new brief treatment. Journal of Behavior Therapy and Experimental Psychiatry. 2004; 35(3): 307-318. https://doi.org/10.1016/j.jbtep.2004.07.001
53. Wells A, Matthews G. Attention and emotion: A clinical prespective. UK: Erlbaum, 1994.
54. Martell C, Addis M, Dimidjian S. Finding the Action in Behavioral Activation: The Search for Empirically Supported Interventions and Mechanisms of Change. In Hayes, S. C., Follette, V. M., & Linehan, M. M (Eds), Mindfulness and acceptance: Expanding the cognitive behavioral tradition. New York: Guilford Press, 2004: 152-167
55. Ritschel LA, Ramirez CL, Jones M, Craighead WE. Behavioral activation for depressed teens: A pilot study. Cognitive and Behavioral Practice. 2011; 18(2): 281-99. https://doi.org/10.1016/j.cbpra.2010.07.002
